Characterization of the UK anthrax vaccine and human immunogenicity

The manufacture of the UK Anthrax vaccine (AVP) focuses on the production of Protective Antigen (PA) from the Bacillus anthracis Sterne strain. Although used for decades, several of AVP’s fundamental properties are poorly understood, including its exact composition, the extent to which proteins othe...

Full description

Bibliographic Details
Published in:Human Vaccines & Immunotherapeutics
Main Authors: Tapasvi Modi, David Gervais, Stuart Smith, Julie Miller, Shaan Subramaniam, Konstantinos Thalassinos, Adrian Shepherd
Format: Article
Language:English
Published: Taylor & Francis Group 2021-03-01
Subjects:
bacillus anthracis
anthrax
anthrax vaccine precipitated
desorption
proteomics
mhc-binding prediction
Online Access:http://dx.doi.org/10.1080/21645515.2020.1799668

Internet

http://dx.doi.org/10.1080/21645515.2020.1799668

Similar Items